SHFA
BCAB icon

SC&H Financial Advisors’s BioAtla BCAB Stock Holding History

SC&H Financial Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,310
Closed -$115K – 149
2024
Q3 		$115K Hold
1,310
– – 0.03% 151
2024
Q2 		$89.8K Hold
1,310
– – 0.02% 142
2024
Q1 		$225K Hold
1,310
– – 0.06% 133
2023
Q4 		$161K Sell
1,310
-113
-8% -$9.8K 0.05% 138
2023
Q3 		$121K Buy
1,423
+995
+232% +$127K 0.04% 130
2023
Q2 		$64.2K Hold
428
– – 0.02% 136
2023
Q1 		$57.4K Buy
+428
New +$77.1K 0.02% 131

Other funds holding BCAB

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

SC&H Financial Advisors's BCAB Position: Q4 2024 in Review

SC&H Financial Advisors sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 1,310 shares — an estimated $115K sold.

SC&H Financial Advisors first reported a position in BCAB in Q1 2023 and held it in 7 quarters. The position peaked at $225K in Q1 2024. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

  • SC&H Financial Advisors reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
  • SC&H Financial Advisors sold 1,310 BioAtla shares in Q4 2024, an estimated $115K.
  • SC&H Financial Advisors first reported a position in BioAtla in Q1 2023 and held it in 7 quarters.
  • SC&H Financial Advisors's BioAtla position peaked at $225K in Q1 2024.
  • 67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on SC&H Financial Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.